Kryski Biomedia

This is an illustration of Revcovi, a new enzyme replacement therapy (ERT) for the treatment of patients with adenosine deaminase severe combined immune deficiency (ADA-SCID). The enzyme uses recombinant technology. A succinimidyl carbamate (SC) linker links to PEG to the rADA protein. Client: Leadiant Biosciences

Keywords: Color, Line with Color, Advertising / Marketing, Editorial, Education, Technology, Product Demonstration, Biotechnology, Molecular Biology, Mechanism of Action (MOA)

© Diana Kryski